Markets

Wall Street's main indexes opened higher on Friday, with investors anticipating progress in bipartisan talks over the next coronavirus aid bill as the Nov. 3 presidential election gets closer.

U.S. business activity increased to a 20-month high in October, but the pace of new business growth and new orders eased slightly amid the lingering COVID-19 pandemic and caution ahead of the Nov. 3 presidential election.

Representatives of Amazon.com Inc in India have refused to appear before a parliamentary panel reviewing the country's privacy bill and that could lead to "coercive action" against the U.S. e-commerce giant, a lawmaker said on Friday.

Representatives of Amazon.com Inc in India have refused to appear before a parliamentary panel reviewing the country's privacy bill and that could lead to "coercive action" against the U.S. e-commerce giant, an Indian lawmaker said on Friday.

KUALA LUMPUR: Malaysia's AirAsia Group has approved and disbursed a RM300 million (US$72 million) loan from Sabah Development Bank to its units as part of the group's fundraising efforts, the budget airline said in a bourse filing on Friday (Oct 23). The airline said the loan was not backed by...

Britain says the post-Brexit trade deal signed with Japan on Friday "secures major wins that would be impossible as part of the EU", though its substance is largely similar to the current EU-Japan accord.

U.S. solar stocks rose on Friday after U.S. Democratic presidential candidate Joe Biden said in the final pre-election debate on Thursday night that if elected he plans to transition to a more climate-friendly economy.

Chinese fintech giant Ant Group's move to earmark a record 80per cent of the Shanghai leg of its US$35 billion dual-listing for strategic investors has led to a scramble among smaller investors for what some see as a once-in-a-lifetime opportunity.

Credit card issuer American Express Co reported a nearly 40per cent slump in quarterly profit on Friday, hurt by lower spending by its users, while it also set aside US$665 million for potential defaults.

Shares of Gilead Sciences Inc rose 6per cent on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the United States.